X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Sterling Biotech with Panacea Biotech - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STERLING BIOTECH vs PANACEA BIOTECH - Comparison Results

STERLING BIOTECH    Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

PANACEA BIOTECH 
   Change

Panacea Biotec is the second largest vaccine producer in India and has been ranked as the third largest biotechnology company in India (as per ABLE Survey 2006). While vaccines account for two-thirds of the company's overall revenues, the balance com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    STERLING BIOTECH PANACEA BIOTECH STERLING BIOTECH/
PANACEA BIOTECH
 
P/E (TTM) x -0.4 -16.7 - View Chart
P/BV x 0.0 2.0 0.7% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 STERLING BIOTECH   PANACEA BIOTECH
EQUITY SHARE DATA
    STERLING BIOTECH
Dec-13
PANACEA BIOTECH
Mar-14
STERLING BIOTECH/
PANACEA BIOTECH
5-Yr Chart
Click to enlarge
High Rs11149 7.1%   
Low Rs382 4.1%   
Sales per share (Unadj.) Rs26.884.1 31.9%  
Earnings per share (Unadj.) Rs-15.0-18.3 81.7%  
Cash flow per share (Unadj.) Rs-5.5-6.7 81.5%  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs54.983.7 65.6%  
Shares outstanding (eoy) m267.8761.25 437.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.31.4 18.9%   
Avg P/E ratio x-0.5-6.3 7.4%  
P/CF ratio (eoy) x-1.3-17.2 7.4%  
Price / Book Value ratio x0.11.4 9.2%  
Dividend payout %00-   
Avg Mkt Cap Rs m1,8627,074 26.3%   
No. of employees `0001.42.8 49.2%   
Total wages/salary Rs m5471,449 37.7%   
Avg. sales/employee Rs Th5,303.31,874.1 283.0%   
Avg. wages/employee Rs Th403.8527.0 76.6%   
Avg. net profit/employee Rs Th-2,959.0-407.7 725.7%   
INCOME DATA
Net Sales Rs m7,1815,154 139.3%  
Other income Rs m43100 42.7%   
Total revenues Rs m7,2235,254 137.5%   
Gross profit Rs m947-766 -123.6%  
Depreciation Rs m2,543711 357.7%   
Interest Rs m4,3771,503 291.2%   
Profit before tax Rs m-5,931-2,881 205.9%   
Minority Interest Rs m011 0.0%   
Prior Period Items Rs m0-6 0.0%   
Extraordinary Inc (Exp) Rs m01,771 0.0%   
Tax Rs m-1,92417 -11,454.2%   
Profit after tax Rs m-4,007-1,121 357.3%  
Gross profit margin %13.2-14.9 -88.7%  
Effective tax rate %32.4-0.6 -5,563.1%   
Net profit margin %-55.8-21.8 256.4%  
BALANCE SHEET DATA
Current assets Rs m14,3353,810 376.2%   
Current liabilities Rs m49,8098,365 595.4%   
Net working cap to sales %-494.0-88.4 558.9%  
Current ratio x0.30.5 63.2%  
Inventory Days Days403156 259.1%  
Debtors Days Days17167 253.8%  
Net fixed assets Rs m55,43214,480 382.8%   
Share capital Rs m26861 437.0%   
"Free" reserves Rs m13,935903 1,543.0%   
Net worth Rs m14,7015,127 286.7%   
Long term debt Rs m9,4785,832 162.5%   
Total assets Rs m73,98819,433 380.7%  
Interest coverage x-0.4-0.9 38.7%   
Debt to equity ratio x0.61.1 56.7%  
Sales to assets ratio x0.10.3 36.6%   
Return on assets %0.52.0 25.5%  
Return on equity %-27.3-21.9 124.6%  
Return on capital %-6.43.6 -176.7%  
Exports to sales %25.924.5 105.6%   
Imports to sales %0.210.2 1.7%   
Exports (fob) Rs m1,8601,264 147.2%   
Imports (cif) Rs m12525 2.3%   
Fx inflow Rs m1,8601,539 120.8%   
Fx outflow Rs m25942 2.6%   
Net fx Rs m1,835597 307.3%   
CASH FLOW
From Operations Rs m1,719599 286.8%  
From Investments Rs m-3,148-438 718.9%  
From Financial Activity Rs m1,426-303 -471.2%  
Net Cashflow Rs m-3-141 2.4%  

Share Holding

Indian Promoters % 33.9 74.5 45.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 0.6 -  
FIIs % 9.9 1.3 761.5%  
ADR/GDR % 16.9 0.0 -  
Free float % 39.3 23.6 166.5%  
Shareholders   21,482 10,259 209.4%  
Pledged promoter(s) holding % 55.9 35.1 159.5%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare STERLING BIOTECH With:   TTK HEALTHCARE  UNICHEM LAB  WYETH LTD  ELDER PHARMA  ALEMBIC LTD  

Compare STERLING BIOTECH With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Finish Flat; IT and Pharma Stocks Witness Selling(Closing)

Share markets in India ended their trading session on a flattish note. Sectoral indices ended on a mixed note with stocks in the IT sector and pharma sector witnessing most of the selling pressure.

Related Views on News

PANACEA BIOTECH Announces Quarterly Results (4QFY18); Net Profit Down 66.5% (Quarterly Result Update)

Jun 20, 2018 | Updated on Jun 20, 2018

For the quarter ended March 2018, PANACEA BIOTECH has posted a net profit of Rs 86 m (down 66.5% YoY). Sales on the other hand came in at Rs 2 bn (up 0.3% YoY). Read on for a complete analysis of PANACEA BIOTECH's quarterly results.

Galaxy Surfactants Ltd. (IPO)

Jan 27, 2018

Should you subscribe to the IPO of Galaxy Surfactants Ltd?

Galaxy Surfactants Ltd. (IPO)

Jan 27, 2018

Should you subscribe to the IPO of Galaxy Surfactants Ltd?

Tata Chem: Suspension of Haldia Operations Drag Bottomline Lower (Quarterly Results Update - Detailed)

Aug 17, 2017

Interruption at Haldia plant and fire at Lostock facility hits operations during the quarter.

Tata Chem: Suspension of Haldia Operations Drag Bottomline Lower (Quarterly Results Update - Detailed)

Aug 17, 2017

Interruption at Haldia plant and fire at Lostock facility hits operations during the quarter.

More Views on News

Most Popular

These Are the Kind of Blue Chips You Should Invest In(The 5 Minute Wrapup)

Nov 9, 2018

All blue chip companies are large caps but all large caps are not blue chips.

Get this Small Cap Logistics Company at a 16% Discount Right Now...(Profit Hunter)

Nov 6, 2018

If you turn the clock back, the current macroeconomic climate is nothing new. The markets have seen them all, and every downcycle has been succeeded by gravity defying gains...more so in the small cap space. This time will be no different.

Insider Buying: These Owner Operators Are Taking Advantage of the Correction(Chart Of The Day)

Nov 2, 2018

We believe insider buying is one of the strongest smart money indicators.

Are You Among The 35% Parents Who Will Not Be Able To Finance Their Child's Future?(Outside View)

Nov 1, 2018

PersonalFN explains the importance of being prepared for your child's future.

Are Fund Houses Opening Up Their NFO Factories Again?(Outside View)

Nov 2, 2018

PersonalFN sheds light on FY 2018-19 so far, the mutual fund industry has collectively launched 84 New Fund Offers (NFOs), of which some are still open for subscription.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

STERLING BIOTECH SHARE PRICE


Nov 5, 2018 (Close)

TRACK STERLING BIOTECH

  • Track your investment in STERLING BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STERLING BIOTECH

STERLING BIOTECH 5-YR ANALYSIS

COMPARE STERLING BIOTECH WITH

MARKET STATS